List of articles with "Harbour BioMed"

Collaboration with AstraZeneca

Collaboration with AstraZeneca

None AstraZeneca Cambridge, Massachusetts biotherapeutics Harbour BioMed
AI Partnership in Drug Development

AI Partnership in Drug Development

China Shanghai AI Collaboration Harbour BioMed Evinova
AI Model for Antibody Discovery

AI Model for Antibody Discovery

United States Generative AI Cambridge Harbour BioMed HCAb Model
Phase II Results: HBM4003

Phase II Results: HBM4003

None Harbour BioMed Tislelizumab HBM4003
2025 Interim Results

2025 Interim Results

China Shanghai Harbour BioMed Immunology Antibody Technology
Yajie Li Joins Harbour BioMed

Yajie Li Joins Harbour BioMed

China Shanghai Biopharmaceutical Harbour BioMed Yajie Li
Harbour BioMed at ESMO

Harbour BioMed at ESMO

None Harbour BioMed Tislelizumab HBM4003
Harbour BioMed Profit Alert

Harbour BioMed Profit Alert

None AstraZeneca Harbour BioMed HBICE
Phase 2 Trial of HBM9378

Phase 2 Trial of HBM9378

None HBM9378 Harbour BioMed Anti-TSLP
Collaboration with Otsuka

Collaboration with Otsuka

China Shanghai Harbour BioMed Otsuka Bispecific T-Cell Engagers
Patent Victory for Harbour BioMed

Patent Victory for Harbour BioMed

China Shanghai Harbour BioMed Biocytogen HCAb Patent
Youchen Chen Appointed CFO

Youchen Chen Appointed CFO

China Shanghai CFO Harbour BioMed Youchen Chen
Harbour BioMed 2024 Results

Harbour BioMed 2024 Results

None biopharmaceuticals Harbour BioMed HCMab Technology
Collaboration for Antibodies

Collaboration for Antibodies

China Beijing AstraZeneca Harbour BioMed Antibody Technology
Élancé's Next-Gen Obesity Solutions

Élancé's Next-Gen Obesity Solutions

None bispecific antibody Harbour BioMed Élancé Therapeutics
Dr. Ian Y. Liu Joins Harbour BioMed

Dr. Ian Y. Liu Joins Harbour BioMed

United States Cambridge Harbour BioMed antibody therapeutics Dr. Ian Y. Liu
Patten Appointed CSO at Harbour

Patten Appointed CSO at Harbour

China Shanghai Harbour BioMed Michael Patten strategy officer
Harbour and Insilico Team Up

Harbour and Insilico Team Up

None Insilico Medicine Harbour BioMed Antibody Discovery
Harbour BioMed Update

Harbour BioMed Update

China Shanghai biotechnology Harbour BioMed antibody therapeutics
New COPD Treatment Approved

New COPD Treatment Approved

China Shanghai Harbour BioMed HBM9378/SKB378 COPD
Harbour BioMed Partnership

Harbour BioMed Partnership

None HBM9378 Windward Bio Harbour BioMed

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.